Krishnan Krish S, PRES, reported a transaction classified as exercise at Krystal Biotech, Inc. involving 8750.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1548005.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
Form 4 relationship flags and nearby filing context
President and CEO
Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 10,200 shares of restricted stock on February 26, 2025. 40,800 Restricted Stock Award…
The closing price on February 26, 2025 of the Company's common stock on the Nasdaq Global Select Market.
25,000 performance stock units ("PSUs") were granted on February 28, 2023. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of cer…
Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 12,500 PSUs on February 28, 2025.
The closing price on February 28, 2025 of the Company's common stock on the Nasdaq Global Select Market.
35,000 restricted stock units ("RSUs") were granted on February 29, 2024. Each RSU represented a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's…
Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 8,750 RSUs on February 28, 2025.
52,500 performance stock units ("PSUs") were granted on February 29, 2024. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of cer…
Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 26,250 PSUs on February 28, 2025.
15,000 PSUs were granted on February 28, 2023, to the Reporting Person's spouse, Suma M. Krishnan. Each PSU represented a contingent right to receive one share of the Company's common stock, subject t…
These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma M. Krishnan.
Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.
Represents number of shares of common stock surrendered to the Company for tax withholding by the Reporting Person's spouse, Suma M. Krishnan, upon the vesting of 7,500 PSUs on February 28, 2025.
45,000 PSUs were granted on February 29, 2024, to the Reporting Person's spouse, Suma M. Krishnan. Each PSU represented a contingent right to receive one share of the Company's common stock, subject t…
Represents number of shares of common stock surrendered to the Company for tax withholding by the Reporting Person's spouse, Suma M. Krishnan, upon the vesting of 22,500 PSUs on February 28, 2025.
Represents number of shares of common stock surrendered to the Company for tax withholding by the Reporting Person's spouse, Suma M. Krishnan, upon the vesting of 7,100 shares of restricted stock on F…
Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.
The option vests in four equal annual installments beginning on February 28, 2026.
Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date.
The number of RSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming the Reporting Person's continued service to the Company on all applicable v…
The RSUs vest in four equal annual installments with the first installment vesting on February 28, 2026.
0 other filings
0 recent txs